FDA Avandia Hearing Update – Committee Votes to Keep Avandia on the Market…
The FDA advisory panel on Avandia voted in favor of keeping Avandia (rosiglitizone) on the market the vote breaks down as…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Daily Archives
July 14, 2010
FDA Avandia Hearing Update – Committee Votes Increased Risk of CV events,…
After almost two days of rigorous debate, the time for the FDA vote on the fate of Avandia is upon us.
The 33 member FDA advisory…
CME Grant Disclosure and Transparency: Company Reports 2009 and 1st Qtr…
We have compiled a chart of companies that disclose their educational grant payments for 2009 and 2010.
In 2009…
Massachusetts Code of Conduct: Harm to Massachusetts Companies and Economy
The medical device industry was pleased last week when the Massachusetts House of Representatives voted 145-4 to repeal the “gift…